Lataa...
Dexmedetomidine attenuates acute paroxysmal sympathetic hyperactivity
We evaluated the curative effect of dexmedetomidine on paroxysmal sympathetic hyperactivity (PSH) in a retrospective study of 72 PSH patients after neurosurgery. Our results showed that dexmedetomidine was superior to propofol for treatment of PSH with respect to: average time needed to reduce parox...
Tallennettuna:
| Julkaisussa: | Oncotarget |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5620316/ https://ncbi.nlm.nih.gov/pubmed/28978176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16920 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|